CURIS INC: Diferență între versiuni

1.253 de octeți adăugați ,  18 septembrie
Pagină nouă: Pagina dedicata companiei CURIS INC listata cu simbolul US.CRIS ==Descriere companie== Curis, Inc. (www.curis.com) is a biotechnology company focused on the development of therapeutics for the treatment of cancer. The Company’s drug candidates include CA-4948 and CI-8993. CA-4948 is an orally available small-molecule inhibitor of Interleukin-I receptor-associated kinase 4, which is undergoing testing in a Phase I open-label dose escalating clinical trial in patients with n...
(Pagină nouă: Pagina dedicata companiei CURIS INC listata cu simbolul US.CRIS ==Descriere companie== Curis, Inc. (www.curis.com) is a biotechnology company focused on the development of therapeutics for the treatment of cancer. The Company’s drug candidates include CA-4948 and CI-8993. CA-4948 is an orally available small-molecule inhibitor of Interleukin-I receptor-associated kinase 4, which is undergoing testing in a Phase I open-label dose escalating clinical trial in patients with n...)
(Nicio diferență)